BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15820763)

  • 1. Technetium labeling of dextran incorporating cysteamine as a ligand.
    Matsunaga K; Hara K; Imamura T; Fujioka T; Takata J; Karube Y
    Nucl Med Biol; 2005 Apr; 32(3):279-85. PubMed ID: 15820763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran.
    Vera DR; Wallace AM; Hoh CK; Mattrey RF
    J Nucl Med; 2001 Jun; 42(6):951-9. PubMed ID: 11390562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of gastric and colonic sentinel nodes through endoscopic administration of 99mTc-DTPA-mannosyl-dextran in pigs.
    Méndez J; Wallace AM; Hoh CK; Vera DR
    J Nucl Med; 2003 Oct; 44(10):1677-81. PubMed ID: 14530486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-labeled mannosyl-neoglycoalbumin for sentinel lymph node identification.
    Takagi K; Uehara T; Kaneko E; Nakayama M; Koizumi M; Endo K; Arano Y
    Nucl Med Biol; 2004 Oct; 31(7):893-900. PubMed ID: 15464391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical studies of [(99m)Tc]DTPA-mannosyl-dextran .
    Hoh CK; Wallace AM; Vera DR
    Nucl Med Biol; 2003 Jul; 30(5):457-64. PubMed ID: 12831982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative biological evaluation of two [99mTc(CO)3]-dextran pyrazolyl mannose conjugates developed for use in sentinel lymph node detection.
    Subramanian S; Pandey U; Morais M; Correia JD; Santos I; Samuel G
    Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):216-23. PubMed ID: 24172653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and development of (99m)tc-'4+1'-labeled dextran-mannose derivatives as potential radiopharmaceuticals for sentinel lymph node detection.
    Giglio J; Fernández S; Jentschel C; Pietzsch HJ; Papadopoulos M; Pelecanou M; Pirmettis I; Paolino A; Rey A
    Cancer Biother Radiopharm; 2013 Sep; 28(7):541-51. PubMed ID: 23651043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of background activity through radiolabeling of antifibrin Fab' with 99mTc-dextran.
    Line BR; Weber PB; Lukasiewicz R; Dansereau RN
    J Nucl Med; 2000 Jul; 41(7):1264-70. PubMed ID: 10914920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
    Ogawa K; Mukai T; Inoue Y; Ono M; Saji H
    J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining dose and injection volume for good performance of a specific radiopharmaceutical for sentinel node detection.
    Núñez EG; de Oliveira EA; da Silva NG; Filho RS
    Nucl Med Biol; 2012 Jan; 39(1):145-53. PubMed ID: 22079036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41.
    Welling MM; Visentin R; Feitsma HI; Lupetti A; Pauwels EK; Nibbering PH
    Nucl Med Biol; 2004 May; 31(4):503-9. PubMed ID: 15093821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione-mediated metabolism of technetium-99m SNS/S mixed ligand complexes: a proposed mechanism of brain retention.
    Nock BA; Maina T; Yannoukakos D; Pirmettis IC; Papadopoulos MS; Chiotellis E
    J Med Chem; 1999 Mar; 42(6):1066-75. PubMed ID: 10090789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (99m)Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model.
    Karczmarczyk U; Markiewicz A; Mikołajczak R; Lisiak E; Bilski M; Pietrzykowski J; Michalik J
    Nucl Med Rev Cent East Eur; 2004; 7(2):107-12. PubMed ID: 15968595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic delivery of 99mTc-labeled dextran acetate particles including cyclosporine A.
    Kim J; Chung KH; Lee CM; Seo YS; Song HC; Lee KY
    J Microbiol Biotechnol; 2008 Sep; 18(9):1599-605. PubMed ID: 18852518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis,
    Wang J; Yang W; Xue J; Zhang Y; Liu Y
    J Labelled Comp Radiopharm; 2017 Dec; 60(14):659-665. PubMed ID: 29023951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoscintigraphy with Tc-99m labeled dextran.
    Ege GN
    J Nucl Med; 1983 Apr; 24(4):370-1. PubMed ID: 6187903
    [No Abstract]   [Full Text] [Related]  

  • 17. A new technetium-99m labeled isonitrile complex 99mTc-TMCHI as a potential blood pool imaging agent.
    Zhang XZh; Wang XB; Zhou JM
    Appl Radiat Isot; 2003 Oct; 59(4):231-5. PubMed ID: 14522230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New bisaminoethanethiol (BAT) ligands which form two interconvertible Tc-99m complexes.
    Oya S; Kung MP; Frederick D; Kung HF
    Nucl Med Biol; 1995 Aug; 22(6):749-57. PubMed ID: 8535335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of a series of 99mTc(CO)3+ lisinopril complexes for in vivo imaging of angiotensin-converting enzyme expression.
    Femia FJ; Maresca KP; Hillier SM; Zimmerman CN; Joyal JL; Barrett JA; Aras O; Dilsizian V; Eckelman WC; Babich JW
    J Nucl Med; 2008 Jun; 49(6):970-7. PubMed ID: 18483087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro characterization and biostability of 99mTc-dextran and its accumulation within the inflamed paws of adjuvant-induced arthritic rats.
    Kellaway IW; Seale L; Spencer PS
    Pharm Res; 1995 Apr; 12(4):588-93. PubMed ID: 7541134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.